
Sign up to save your podcasts
Or


Pulitzer-winning physician Siddhartha Mukherjee referred to cancer as “The Emperor of All Maladies.” Now, Mukherjee is one of many contributors to “A New Deal for Cancer – Lessons From A 50 Year War.”
This hour on Where We Live, we talk about the legacy and shortcomings of this war, including the lack of access to cancer care for some populations, a byzantine drug reimbursement system, the lack of incentives for preventive testing, and corporatization of physician-owned clinics. We also discuss the promise of President Joe Biden’s newly relaunched Cancer Moonshot program, and barriers to its liftoff.
The science of cancer has advanced significantly since the National Cancer Act was first signed in 1971. How will the country work towards fewer deaths and equitable treatment for all Americans over the next 50 years?
GUESTS:
Abbe R. Gluck: Alfred M. Rankin Professor of Law and Faculty Director,
Solomon Center for Health Law and Policy, Yale Law School. Professor of Medicine, Yale School of Medicine. Editor of “A New Deal for Cancer – Lessons From A 50 Year War”
Dr. Charles S. Fuchs: Senior Vice President – Global Head of Hematology and Oncology Product Development, Genentech & Roche. Editor of “A New Deal for Cancer – Lessons From A 50 Year War”
Giselle Carlotta MacDonald: Executive Director, Project Access-New Haven
Support the show: http://wnpr.org/donate
See omnystudio.com/listener for privacy information.
By Connecticut Public Radio4.2
5656 ratings
Pulitzer-winning physician Siddhartha Mukherjee referred to cancer as “The Emperor of All Maladies.” Now, Mukherjee is one of many contributors to “A New Deal for Cancer – Lessons From A 50 Year War.”
This hour on Where We Live, we talk about the legacy and shortcomings of this war, including the lack of access to cancer care for some populations, a byzantine drug reimbursement system, the lack of incentives for preventive testing, and corporatization of physician-owned clinics. We also discuss the promise of President Joe Biden’s newly relaunched Cancer Moonshot program, and barriers to its liftoff.
The science of cancer has advanced significantly since the National Cancer Act was first signed in 1971. How will the country work towards fewer deaths and equitable treatment for all Americans over the next 50 years?
GUESTS:
Abbe R. Gluck: Alfred M. Rankin Professor of Law and Faculty Director,
Solomon Center for Health Law and Policy, Yale Law School. Professor of Medicine, Yale School of Medicine. Editor of “A New Deal for Cancer – Lessons From A 50 Year War”
Dr. Charles S. Fuchs: Senior Vice President – Global Head of Hematology and Oncology Product Development, Genentech & Roche. Editor of “A New Deal for Cancer – Lessons From A 50 Year War”
Giselle Carlotta MacDonald: Executive Director, Project Access-New Haven
Support the show: http://wnpr.org/donate
See omnystudio.com/listener for privacy information.

91,142 Listeners

38,473 Listeners

6,755 Listeners

43,765 Listeners

38,708 Listeners

9,168 Listeners

3,977 Listeners

58 Listeners

6,329 Listeners

343 Listeners

14,638 Listeners

112,617 Listeners

13 Listeners

3 Listeners

16,246 Listeners

46 Listeners

98 Listeners

18 Listeners

2 Listeners

0 Listeners

79 Listeners

29 Listeners

24 Listeners

16,081 Listeners

0 Listeners

9 Listeners

21 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

44 Listeners

599 Listeners